Le Lézard
Classified in: Health, Science and technology, Business
Subjects: PDT, VEN

Bend Financial Set to Launch Disruptive Health Savings Account Platform


Bend Financial is a Boston-based technology and services company that provides health savings account and financial wellness solutions to individuals, employers, and organizations in the group benefits distribution market. Its innovative approach and product offerings simplify the use of HSAs while making the product attractive to all types of healthcare consumers.

BOSTON, April 18, 2018 /PRNewswire/ -- Bend Financial, co-founded and led by a proven team with deep experience at the intersection of financial services and consumer-directed healthcare, is poised to disrupt the increasingly essential Health Savings Account (HSA) market.  The company is backed by funding from .406 Ventures and RRE Ventures.

Bend Financial's powerful platform, Bend HSA, launches later in 2018. Bend HSA fulfills unmet needs by dramatically evolving the consumer HSA experience while delivering substantial benefits to employers and an expansive array of partners in the HSA distribution network.

"HSAs are an increasingly important benefit that can be hard to understand or effectively use, which has caused challenges for consumers and employers," said Raju Rishi, General Partner, RRE Ventures. "It has been far too long since the HSA market has seen true innovation to help address these challenges. Bend is changing that with the right product and the right team, at the right time."

HSA account enrollment continues to rise and is expected to top 30 million by 2020. Bend HSA aligns with this great market opportunity and resolves the challenges with current market offerings. The platform makes HSAs easy for everyone to use, maximizes tax benefits, and solves the fragmented and dated user experience.

Bend HSA gives employers an opportunity to offer a truly inventive product that will drive higher utilization of HSAs while increasing employee satisfaction. It allows health plans, brokers, third-party administrators, and other organizations involved in benefit administration to provide an innovative and differentiated solution.

"The combination of Bend's outstanding team, the enormous market size, and the potential for disruption ? this is exactly the type of opportunity that we back at .406," said Liam Donohue, Managing Partner and co-founder of .406 Ventures. "We could not be more excited to partner with Tom again and to join RRE as a founding investor."

Bend Financial is led by Tom Torre, a serial entrepreneur who has steered venture- and private equity-backed enterprises to successful exits. He has more than 20 years of financial services and consumer-directed healthcare experience. Torre co-founded Bend Financial with startup technology veteran Gary Rush, corporate finance and operations expert Gregg Santabarbara, and consumer healthcare experience innovator Kerry Leonard.

"Our concept is simple. We think HSAs should be easy for everyone to use, and we've built a genuinely innovative and helpful product ? coupled with an incredible team and investors ? to make it happen," said Torre.

About Bend Financial

Bend Financial is a Boston-based technology and services company that provides health savings account and financial wellness solutions to individuals, employers, and organizations in the group benefits distribution market. Its innovative approach and product offerings simplify the use of HSAs while making the product attractive to all types of healthcare consumers.

Media Contact
Gina Veazey
703-254-6276
[email protected]

SOURCE Bend Financial, Inc.


These press releases may also interest you

at 06:50
Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved BEQVEZtm (fidanacogene elaparvovec-dzkt) for the treatment of adults with moderate to severe hemophilia B who currently use factor IX (FIX) prophylaxis...

at 06:08
The Annual General Meeting of Bioretec Ltd was held on 26 April 2024 in Tampere, Finland. The Annual General Meeting approved the financial statements for the financial year 1 January?31 December 2023 and resolved to discharge the members of the...

at 06:00
IDEAYA Biosciences, Inc. , a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced that, on April 25, 2024, the Compensation Committee of IDEAYA's Board of Directors granted...

at 06:00
-- Diluted EPS of $2.16; Adjusted Diluted EPS of $2.26 ---- Increases 2024 Full Year Guidance -- 2024 adjusted diluted EPS of $2.26, up over 7% from $2.11 in the first quarter of 2023.Increases 2024 full year adjusted diluted EPS guidance by $0.10 to...

at 06:00
Avantor, Inc. , a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today reported financial results for its first...

at 05:12
Swedish Orphan Biovitrum AB (publ) (Sobi®) has established a medium term note programme with a framework amount of SEK 10 billion or the equivalent thereof in EUR (the "MTN Programme"). For this purpose, Sobi has prepared a base prospectus, which...



News published on and distributed by: